# A Trial of Inflammatory Markers, Depressive Symptoms, and Heart Disease

> **NCT00208117** · PHASE1 · TERMINATED · sponsor: **New York State Psychiatric Institute** · enrollment: 7 (actual)

## Conditions studied

- Depression
- Coronary Artery Disease (CAD)
- Acute Coronary Syndrome (ACS)

## Interventions

- **DRUG:** Sertraline (Zoloft)
- **DRUG:** Simvastatin (Zocor)

## Key facts

- **NCT ID:** NCT00208117
- **Lead sponsor:** New York State Psychiatric Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2005-04
- **Primary completion:** 2009-01
- **Final completion:** 2009-01
- **Target enrollment:** 7 (ACTUAL)
- **Why stopped:** Unable to enroll subjects
- **Last updated:** 2012-05-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00208117

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00208117, "A Trial of Inflammatory Markers, Depressive Symptoms, and Heart Disease". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00208117. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*